+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Solutions Market - Global Forecast 2026-2032- Product Image
Intravenous Solutions Market - Global Forecast 2026-2032- Product Image
Sale

Intravenous Solutions Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454935
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Intravenous Solutions Market is projected to reach USD 17.90 Billion in 2026. It is expected to continue growing at a CAGR of 9.44%, reaching USD 30.81 Billion by 2032.

Intravenous solutions are foundational sterile drug products used to restore fluid balance, deliver electrolytes, support parenteral nutrition, and provide medication diluents across emergency care, surgery, oncology, intensive care, and home infusion. Core products such as normal saline, dextrose solutions, lactated Ringer’s solution, amino acid formulations, lipid emulsions, and specialty admixtures remain essential to modern clinical workflows and medication administration.

Demand for IV solutions is supported by verified structural drivers, including rising surgical volumes, higher chronic disease prevalence, aging populations, growth in outpatient infusion, and increased use of intravenous therapy in critical care. Regulatory expectations from agencies such as the FDA and EMA, along with pharmacopeial standards including USP requirements for sterile preparation and compounding, continue to elevate expectations for sterility assurance, container closure integrity, labeling accuracy, traceability, and supply continuity.

Transformative Shifts in the Intravenous Solutions Landscape

The intravenous solutions landscape is shifting from volume-driven commodity supply toward resilient, technology-enabled, and clinically differentiated fluid management. Hospitals and ambulatory infusion providers are prioritizing ready-to-administer formats, closed-system compatibility, standardized concentrations, and barcoded labeling to reduce medication errors, improve traceability, and accelerate nursing workflows.

At the same time, recurring sterile injectable shortages and logistics disruptions have made domestic manufacturing capacity, multi-source procurement, inventory visibility, and strategic stock management key priorities for healthcare systems. The industry is also adapting to sustainability pressure through lighter packaging, optimized sterilization processes, reduced overfill waste, and responsible disposal practices, while maintaining strict compliance with aseptic manufacturing, good manufacturing practice, pharmacovigilance, and product quality requirements.

Cumulative Impact of Artificial Intelligence on IV Solutions

Artificial intelligence is increasingly influencing intravenous solutions through demand forecasting, production planning, quality analytics, and clinical decision support. AI-enabled forecasting can improve allocation of high-use IV fluids during seasonal surges, disaster response, elective procedure recovery, or hospital shortages by analyzing procurement history, admission trends, procedure volumes, regional utilization patterns, and inventory movement.

In manufacturing, machine vision and anomaly detection can support inspection of particulate matter, fill volume, seal integrity, container defects, and labeling consistency. In clinical environments, AI connected to electronic health records, pharmacy systems, and smart infusion platforms may help identify dosing conflicts, renal-risk patients, electrolyte-related alerts, and infusion deviations, strengthening patient safety when deployed with validated governance, human oversight, auditability, and cybersecurity controls.

Key Regional Insights Across the Global IV Solutions Market

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital infrastructure, surgical capacity, chronic disease management, and local pharmaceutical manufacturing. The region also benefits from high patient volumes, expanding private healthcare networks, and rising adoption of standardized infusion practices. North America remains a high-value region led by the United States and Canada, where FDA oversight, USP sterile compounding standards, smart pump adoption, medication safety initiatives, and shortage-prevention programs influence product design, procurement, and inventory management.

Europe emphasizes harmonized quality expectations, cost containment, pharmacovigilance, and environmentally responsible healthcare delivery, with demand shaped by advanced hospital networks, aging populations, and strong public procurement systems. Latin America, led by Brazil and Mexico, is improving access through public and private healthcare investment, broader hospital coverage, and demand for essential sterile fluids. The Middle East is supported by GCC hospital modernization, tertiary care expansion, and medical tourism, while Africa shows sustained need for reliable essential fluids, robust distribution, cold-chain-independent logistics, and affordable sterile supply across public health systems.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is being lifted by expanding universal health coverage, medical tourism, urban hospital development, and investment in private healthcare facilities, creating opportunities for cost-efficient sterile fluids, ready-to-use formats, and dependable regional distribution. The GCC is prioritizing healthcare localization, tertiary care expansion, emergency preparedness, and pharmaceutical supply security, which supports regional partnerships, advanced warehousing, and stronger procurement frameworks for critical hospital supplies.

The European Union shapes IV solutions requirements through harmonized regulation, pharmacovigilance, sustainability policies, and high expectations for traceability and quality assurance. BRICS countries represent scale, manufacturing depth, rising hospital utilization, and broad public health demand, although procurement structures, pricing controls, and regulatory pathways vary widely. G7 markets remain innovation-led, with strong emphasis on patient safety, sterile injectable quality, digital traceability, and shortage prevention. NATO members also prioritize healthcare preparedness, resilient medical stockpiles, emergency response capacity, and continuity of essential sterile medical products during crises.

Key Country Insights for Intravenous Solutions Demand

The United States leads in premium sterile injectable demand, hospital standardization, smart infusion adoption, and shortage mitigation, while Canada emphasizes safety, public procurement, bilingual labeling requirements, and equitable access across provincial health systems. Mexico and Brazil are important Latin American markets supported by expanding hospital networks, public health programs, and consistent demand for essential IV fluids used in emergency, surgical, and inpatient care. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature healthcare infrastructure with cost-control pressure, antimicrobial stewardship, and procurement discipline, while Russia maintains demand through large public hospital systems, domestic production priorities, and regional distribution needs.

China and India offer scale, local manufacturing capacity, rising procedure volumes, and growing demand from both public and private hospitals. Japan and South Korea favor high-quality, technology-integrated care supported by advanced hospital systems, aging demographics, and strong quality expectations. Australia is shaped by strict regulatory oversight, remote healthcare logistics, centralized hospital procurement standards, and the need to maintain dependable supply across geographically dispersed care settings.

Actionable Recommendations for IV Solutions Industry Leaders

Industry leaders should strengthen sterile manufacturing resilience by diversifying suppliers, qualifying redundant production sites, and improving visibility across resin, packaging components, active ingredients, excipients, sterilization inputs, and finished-fluid supply chains. Investment in automated inspection, validated analytics, environmental monitoring, and quality-by-design processes can reduce batch risk and support regulatory compliance.

Commercial teams should prioritize clinically useful differentiation, including ready-to-administer products, standardized concentrations, closed-system compatibility, clear labeling, barcode-enabled traceability, and packaging that improves storage and handling. Leaders should also align with hospital sustainability goals, develop shortage-response protocols, maintain transparent communication with healthcare providers, and use real-world utilization data to support value-based procurement discussions without compromising patient safety or product availability.

Research Methodology for IV Solutions Market Intelligence

This executive summary is developed through structured secondary research and market intelligence synthesis using verified public-domain sources, regulatory guidance, clinical standards, hospital procurement trends, healthcare infrastructure indicators, and peer-reviewed clinical literature. Key reference points include FDA and EMA guidance, USP sterile compounding standards, WHO essential medicines frameworks, national health statistics, pharmacovigilance requirements, and published evidence on fluid therapy, parenteral nutrition, and medication safety.

The methodology triangulates qualitative and quantitative signals across product categories, care settings, regional healthcare investment, disease burden, manufacturing capacity, regulatory requirements, and supply chain risk. Insights are reviewed for consistency, relevance, and traceability to ensure the content supports executive decision-making without relying on unverified claims, market sizing, market share, or forecasting assumptions.

Conclusion: The Future of Intravenous Solutions

The intravenous solutions market remains essential to acute care, chronic disease treatment, emergency medicine, surgery, intensive care, oncology, parenteral nutrition, and outpatient infusion. Demand is supported by demographic pressure, higher healthcare utilization, surgical recovery needs, critical care requirements, and expanding access to sterile therapies across developed and emerging healthcare systems.

The most competitive organizations will combine reliable manufacturing, regulatory excellence, digital supply visibility, and clinically aligned product innovation. As AI, automation, sustainability expectations, and regional supply resilience become more important, suppliers that deliver safe, available, traceable, and workflow-friendly IV solutions will be best positioned to support healthcare systems and capture long-term market value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Intravenous Solutions Market, by Product Type
7.1. Introduction
7.2. Colloids
7.3. Crystalloids
7.3.1. Balanced Solutions
7.3.2. Unbalanced Solutions
8. Intravenous Solutions Market, by Packaging Type
8.1. Introduction
8.2. Bottles
8.3. Concentrates
8.4. Pre-Mixed Bags
9. Intravenous Solutions Market, by Nutrition Class
9.1. Introduction
9.2. Total Parenteral Nutrition (TPN)
9.3. Peripheral Parenteral Nutrition (PPN)
10. Intravenous Solutions Market, by Tonicity
10.1. Introduction
10.2. Isotonic Solutions
10.3. Hypotonic Solutions
10.4. Hypertonic Solutions
11. Intravenous Solutions Market, by Application
11.1. Introduction
11.2. Critical Care
11.3. Emergency Care
11.4. Nutritional Support
11.5. Surgical Procedures
12. Intravenous Solutions Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.3. Home Healthcare Providers
12.4. Hospitals
13. Intravenous Solutions Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
14. Intravenous Solutions Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Intravenous Solutions Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Intravenous Solutions Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Amanta Healthcare Ltd.
18.2. Anhui Medipharm Co. Ltd
18.3. B. Braun SE
18.4. Baxter International Inc.
18.5. Becton, Dickinson and Company
18.6. Enzymes Pharmaceuticals
18.7. Eurolife Healthcare Pvt. Ltd.
18.8. Fresenius Kabi AG
18.9. Grifols, S.A.
18.10. ICU Medical, Inc.
18.11. JW Life Science Corporation
18.12. Laboratoires Aguettant S.A.
18.13. Lxir Medilabs Pvt. Ltd.
18.14. Nipro Corporation
18.15. Nymak Pharma Ltd.
18.16. Otsuka Holdings Co., Ltd.
18.17. Pfizer Inc.
18.18. Salius Pharma Private Limited
18.19. Schwitz Biotech
18.20. Sichuan Kelun Pharmaceutical Co., Ltd.
18.21. Soxa Formulations & Research Pvt. Ltd.
18.22. Terumo Corporation
18.23. Trumac Healthcare
18.24. Varni Corporation
18.25. Vifor Pharma Management Ltd.
List of Figures
FIGURE 1. GLOBAL INTRAVENOUS SOLUTIONS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL INTRAVENOUS SOLUTIONS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2025 VS 2032 (%)
FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL COLLOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL COLLOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL COLLOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CRYSTALLOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CRYSTALLOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CRYSTALLOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BALANCED SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BALANCED SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BALANCED SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL UNBALANCED SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL UNBALANCED SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL UNBALANCED SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BOTTLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BOTTLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BOTTLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONCENTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CONCENTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CONCENTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PRE-MIXED BAGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PRE-MIXED BAGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PRE-MIXED BAGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TOTAL PARENTERAL NUTRITION (TPN) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL TOTAL PARENTERAL NUTRITION (TPN) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL TOTAL PARENTERAL NUTRITION (TPN) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ISOTONIC SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ISOTONIC SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ISOTONIC SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HYPOTONIC SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HYPOTONIC SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HYPOTONIC SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HYPERTONIC SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HYPERTONIC SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL HYPERTONIC SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CRITICAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CRITICAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CRITICAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL EMERGENCY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL EMERGENCY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL EMERGENCY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NUTRITIONAL SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NUTRITIONAL SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NUTRITIONAL SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 104. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 106. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 107. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 108. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 109. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 110. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 111. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. EUROPE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 122. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 125. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 126. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 127. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 128. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 129. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 135. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 136. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 137. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 138. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. ASEAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 144. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 145. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 146. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 147. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. GCC INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 159. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 162. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 163. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 164. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 165. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. BRICS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 171. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 172. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 173. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 174. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. G7 INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 179. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 180. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 181. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 182. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 183. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. NATO INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 197. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 199. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 200. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 201. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 202. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 206. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 208. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 209. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 210. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 211. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 232. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 235. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 236. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 237. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 238. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 241. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 244. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 245. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 246. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 247. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 254. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 262. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 263. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 264. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 265. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 268. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 269. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 270. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 271. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 272. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 273. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 274. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 277. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 278. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 279. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 280. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 281. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 282. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 283. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 288. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 289. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 290. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 291. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 292. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 297. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 298. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 299. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 300. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 301. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITION CLASS, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TONICITY, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 322. GLOBAL INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 323. GLOBAL INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co. Ltd
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Enzymes Pharmaceuticals
  • Eurolife Healthcare Pvt. Ltd.
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science Corporation
  • Laboratoires Aguettant S.A.
  • Lxir Medilabs Pvt. Ltd.
  • Nipro Corporation
  • Nymak Pharma Ltd.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited
  • Schwitz Biotech
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Soxa Formulations & Research Pvt. Ltd.
  • Terumo Corporation
  • Trumac Healthcare
  • Varni Corporation
  • Vifor Pharma Management Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 17.9 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.81 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 259 Pages
  • Global
From
Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), End Use (Home, Hospitals, Infusion Centers), and Region with Growth Forecasts, 2026-2033 - Product Image

Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), End Use (Home, Hospitals, Infusion Centers), and Region with Growth Forecasts, 2026-2033

  • Report
  • 190 Pages
  • Global
From
Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2026-2034 - Product Image

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2026-2034

  • Report
  • 135 Pages
  • Global
From
Intravenous Solutions Market Report 2026 - Product Image

Intravenous Solutions Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Intravenous Solutions Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Intravenous Solutions Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.